Diabetes Mellitus, Type 2

• Novo Nordisk Investigational Site — Birmingham, Alabama, United States
• Novo Nordisk Investigational Site — Birmingham, Alabama, United States
• Novo Nordisk Investigational Site — Peoria, Arizona, United States
• Novo Nordisk Investigational Site — Little Rock, Arkansas, United States

• Novo Nordisk Investigational Site — Anniston, Alabama, United States
• Novo Nordisk Investigational Site — Birmingham, Alabama, United States
• Novo Nordisk Investigational Site — Pell City, Alabama, United States
• Novo Nordisk Investigational Site — Hawaiian Gardens, California, United States

• Novo Nordisk Investigational Site — Phoenix, Arizona, United States
• Novo Nordisk Investigational Site — Anaheim, California, United States
• Novo Nordisk Investigational Site — Fresno, California, United States
• Novo Nordisk Investigational Site — Lomita, California, United States

• Winthrop-University Hospital — Mineola, New York, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Singapore

Not specified

• Novo Nordisk Investigational Site — Graz, Austria

• Phoenix, Arizona, United States
• San Diego, California, United States
• Wilmington, Delaware, United States
• Hollywood, Florida, United States

• National Centre for Sport and Exercise Medicine, Loughborough University — Loughborough, United Kingdom

• Clinical Nutrition Reseach Centre — Singapore